Month: June 2020

IRVINE, Calif., June 03, 2020 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global provider of intelligent edge and secure data management solutions for the Industrial Internet of Things (IoT), today announced that its xPico 250 IoT gateway is being used by Tangen Biosciences in the development of its rapid and sensitive molecular diagnostic test for detection of SARS-CoV-2, the causative agent for COVID-19. “Lantronix’s xPico 250 IoT gateway gave us the small, secure multi-protocol connectivity solution we needed for our GeneSparkTM analyzer on which our COVID-19 molecular assay will be running,” said Ting Yi, Ph.D., MBA and Director of Business Development for Tangen Biosciences Inc. “With the xPico 250, we will be able to accelerate the timeline to deliver the GeneSpark design in compliance with the FDA’s Emergency Use...

DENVER, CO, June 03, 2020 (GLOBE NEWSWIRE) — Intrepid Potash Inc. (NYSE:IPI) (“Intrepid”) today announced that on June 2, 2020 it received written notice from the New York Stock Exchange (“NYSE”)  stating that Intrepid had regained compliance with the applicable NYSE minimum share price requirement.On April 17, 2020, Intrepid previously received notice from the NYSE that its stock price had fallen out of compliance with NYSE continued listing standards. Under NYSE listing standards, Intrepid could regain compliance at any time during the original 6 month cure period if its common stock had a closing price of at least $1.00 per share on the last trading day of any calendar month during the cure period and an average closing price of at least $1.00 per share of common stock over the 30-trading-day period ending on the last trading...

Multiple Complete Responses Observed in Advanced Cutaneous Squamous Cell CarcinomaHigh Rate of Deep Responses in Anti-PD-1 / Anti-CTLA-4 Refractory MelanomaAnnounces Intention to Commence Clinical Development in Anti-PD-1 Refractory Non-Small Cell Lung CancerWOBURN, Mass., June 03, 2020 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, today announced new interim data presented from the Phase 2 part of its Phase 1/2 clinical trial of RP1 in combination with Opdivo® that continues to provide strong support for its lead indications of cutaneous squamous cell carcinoma (CSCC) and anti-PD-1 refractory melanoma.“CSCC is a significant commercial opportunity that we believe has the potential to drive substantial value for the company....

NEW YORK, June 03, 2020 (GLOBE NEWSWIRE) — Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will present at the Goldman Sachs 41st Annual Global Healthcare Conference on Wednesday, June 10, 2020 at 9:40 a.m. ET. The conference will be held in a virtual meeting format.Webcast information for this event will be accessible on the Events page under the Investor Relations section of the Applied Therapeutics website at www.appliedtherapeutics.com. A replay will also be available following the webcast.About Applied Therapeutics Inc.Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against...

OTTAWA, June 03, 2020 (GLOBE NEWSWIRE) — HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) is proud to launch new 30 gram medical flower format for its popular high-THC strain Tsunami under HEXO medical cannabis.HEXO has been dedicated to providing Canadian clients high quality medical cannabis since 2015. A year ago, the Company updated its medical packaging to comply with the Cannabis Regulations, resulting in smaller product formats.  HEXO is proud to launch a new 30 g format offered in a resealable, odour-proof and child-resistant pouch.“We know our medical clients have been waiting for this opportunity to purchase a higher volume of cannabis without excess packaging,” said HEXO CEO and co-founder Sebastien St-Louis. “Our Tsunami flower benefits from enhanced humidity controls for maximum freshness and to promote...

OTTAWA, 03 juin 2020 (GLOBE NEWSWIRE) — HEXO Corp (« HEXO », ou la « Société ») (TSX : HEXO ; NYSE : HEXO) annonce avec fierté le lancement, sous la division HEXO cannabis médical, d’un nouveau format de 30 grammes de fleurs de sa populaire souche Tsunami à haute teneur en THC. Depuis 2015, HEXO vise à fournir du cannabis médical de haute qualité aux clients canadiens. Il y a un an, la Société a modifié son emballage médical pour se conformer à la réglementation sur le cannabis, entraînant une réduction des formats de produits.  HEXO est fière de lancer un nouveau format de 30 g présenté dans un sachet refermable, étanche aux odeurs et à l’épreuve des enfants.« Nous savons que nos clients médicaux attendaient cette opportunité pour acheter un plus grand volume de cannabis sans emballage excessif », a déclaré Sébastien St-Louis,...

BEIJING, June 03, 2020 (GLOBE NEWSWIRE) — Secoo Holding Limited (NASDAQ:  SECO) (together with its affiliates, “Secoo”), Asia’s largest online integrated upscale products and services platform, and Qudian, Inc. (NYSE:  QD) (together with its affiliates, “Qudian”), a leading technology platform empowering the enhancement of online consumer finance experience in China, announced today that Secoo and Qudian have entered into a definitive agreement, pursuant to which Qudian has agreed to purchase a total of up to 10,204,082 newly issued Class A ordinary shares of Secoo for an aggregate purchase price of up to US$100,000,003.60, reflecting a per share purchase price of US$9.80.Following the completion of all transactions contemplated under the definitive agreement, Qudian will hold approximately 28.9% of Secoo’s issued and outstanding...

Helsinki, Finland – June 3, 2020 – SSH Communications Security Corporation announced that SSH Founder Tatu Ylönen has yesterday sold 4.93 million shares in SSH to investment fund Accendo Capital SICAV, SIF. The amount corresponds to approxi­mately 12.7% of the company’s total shares outstanding.With this transaction, Accendo becomes the largest shareholder of SSH, with 29.2% of the company. Tatu Ylönen is now the second-largest shareholder of SSH after the sale with 18.0% of the company.Accendo Capital is an investment fund focusing on creating shareholder value through active ownership in publicly listed Northern European companies that are driving, or benefiting from, technological innovation.“This transaction is a logical continuation of the initial transaction on May 22, 2020, and it is aligned with our investment strategy. We seek...

Helsinki – 3.6.2020 – SSH Communications Security Oyj ilmoitti, että yhtiön perustaja Tatu Ylönen on eilen myynyt 4,93 miljoonaa SSH:n osaketta sijoitusrahasto Accendo Capital SICAV, SIF:lle. Nämä osakkeet vastaavat noin 12,7% SSH:n osakekannasta.Kaupan myötä Accendosta tulee SSH:n suurin omistaja 29,2% osuudella. Tatu Ylönen on kaupan jälkeen SSH:n toiseksi suurin omistaja 18,0% osuudella.Accendo Capital on sijoitusrahasto, joka keskittyy omistaja-arvon kasvattamiseen aktiivisen omistajuuden kautta. Accendo sijoittaa julkisesti listattuihin pohjoiseurooppalaisiin yhtiöihin, joka kehittävät tai hyödyntävät uutta teknologiaa.“Tämä kauppa on looginen jatko 22.5.2020 tehdylle kaupalle ja se on sijoitusstrategiamme mukainen. Haemme merkittäviä vähemmistöosuuksia ja tyypillisesti olemme aktiivisia yhtiöiden hallituksissa pitkän ajan omistaja-arvon...

Bollène, le 3 juin 2020 – 12h30 (CET)Communiqué de pressePour diffusion immédiateASSEMBLEE GENERALE MIXTEAvis de convocationLes actionnaires de la société EGIDE sont invités à participer à l’assemblée générale mixte qui se déroulera le vendredi 19 juin 2020 au siège de l’entreprise à Bollène à 14 h 00.Dans le contexte de l’épidémie du Covid-19 et des mesures administratives prises pour limiter ou interdire les rassemblements collectifs pour des motifs sanitaires, l’attention des actionnaires est appelée sur le fait que les modalités d’organisation et de participation des actionnaires à cette Assemblée Générale Mixte du 19 juin 2020 ont été aménagées.Conformément à l’article 4 de l’ordonnance 2020-321 du 25 mars 2020 prise dans le cadre de l’habilitation conférée par la loi d’urgence pour faire face à l’épidémie de covid-19...